A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma

被引：0
|
作者：
Joaquín Casal Rubio
S. Vázquez
F. Vázquez
M. Amenedo
J. L. Fírvida
J. R. Mel
G. Huidobro
E. Álvarez
M. Lázaro
G. Alonso
I. Fernández
机构：
[1] Hospital do Meixoeiro,Department of Medical Oncology
[2] Complejo Hospitalario Xeral-Calde,undefined
[3] Hospital Arquitecto Marcide,undefined
[4] Centro Oncológico de Galicia,undefined
[5] Complejo Hospitalario,undefined
[6] Hospital Juan Canalejo,undefined
[7] Hospital Montecelo,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Chemotherapy; Cisplatin; Docetaxel; Gemcitabine; Non-small cell lung cancer; Phase II trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：379 / 384
页数：5
相关论文
共 50 条
  • [31] Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer
    Chen, YM
    Perng, RP
    Whang-Peng, J
    Wu, HW
    Lin, WC
    Tsai, CM
    LUNG CANCER, 2000, 30 (03) : 199 - 202
  • [32] A randomized phase iib trial of gemcitabine and cisplatin (GC) versus gemcitabine and docetaxel (GD) in stage IIIB/IV advanced non-small cell lung cancer (NSCLC) -: An Galician lung cancer group study
    Rubio, J. Casal
    Estevez, S. Vazquez
    Rivera, F. Vazquez
    Salfago, Mercedes
    Llorca, Cristina
    Ramos, Manuel
    Perez, Eva
    Cervera, Jose M.
    Garcia, Jesus
    Gomez, Jesus Garcia
    Mata, Jesus Garcia
    ANNALS OF ONCOLOGY, 2006, 17 : 224 - 224
  • [33] Phase II study of regimen of gemcitabine and cisplatin in advanced non-small cell lung cancer
    Chen, SCH
    Lin, MC
    Chang, JWC
    Wang, SW
    Lee, CH
    Tsao, TCY
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (11) : 494 - 498
  • [34] Nedaplatin/gemcitabine versus carboplatin/gemcitabine in treatment of advanced non-small cell lung cancer: A randomized clinical trial
    Yang, Jin-ji
    Zhou, Qing
    Liao, Ri-qiang
    Huang, Yi-sheng
    Xu, Chong-rui
    Wang, Zhen
    Wang, Bin-chao
    Chen, Hua-jun
    Wu, Yi-long
    CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (02) : 97 - 102
  • [35] Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial
    Georgoulias, Vassilis
    Androulakis, Nikolaos
    Kotsakis, Athanasios
    Hatzidaki, Dora
    Syrigos, Kostas
    Polyzos, Aris
    Agelidou, Athina
    Varthalitis, Loannis
    Ziras, Nikoalos
    Agelidou, Maria
    Chandrinos, Vassilis
    Boukovinas, Loannis
    Geroyianni, Alexandra
    Vamakas, Larnbros
    Mavroudis, Dirnitris
    LUNG CANCER, 2008, 59 (01) : 57 - 63
  • [36] Nedaplatin/Gemcitabine Versus Carboplatin/Gemcitabine in Treatment of Advanced Non-small Cell Lung Cancer: A Randomized Clinical Trial
    Jin‐ji Yang
    Chinese Journal of Cancer Research, 2012, 24 (02) : 97 - 102
  • [37] Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III A/B Unresectable Non-small Cell Lung Cancer
    Movsas, Benjamin
    Langer, Corey J.
    Ross, Helen J.
    Wang, Luhua
    Jotte, Robert M.
    Feigenberg, Steve
    Xu, Feng
    Huang, Chao H.
    Monberg, Matthew J.
    Obasaju, Coleman K.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : 673 - 679
  • [38] Docetaxel-gemcitabine versus cisplatin-gemcitabine plus sequential docetaxel in the first-line treatment of metastatic non-small cell lung cancer (NSCLC): interim results of a randomized Phase II trial
    Binder, Daniel
    Beinert, Thomas
    Schweisfurth, Hans
    Grah, Christian
    Temmestfeld-Wollbrueck, Bettina
    Schaeper, Christoph
    Mueller-Hagen, Gerit
    Schuermann, Dirk
    Suttorp, Norbert
    ANNALS OF ONCOLOGY, 2004, 15 : 178 - 178
  • [39] A phase II of gemcitabine in advanced non-small cell lung cancer
    Koynov, K
    Tzekova, V
    Mincheva, N
    Scherer, A
    Krejcy, K
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 231 - 234
  • [40] Elderly patients with advanced non-small cell lung cancer - A phase II study with weekly cisplatin and gemcitabine
    Berardi, R
    Porfiri, E
    Scartozzi, M
    Lippe, P
    Silva, RR
    Nacciarriti, D
    Menichetti, ET
    Tummarello, D
    Carle, F
    Piga, A
    Cellerino, R
    ONCOLOGY, 2003, 65 (03) : 198 - 203
12345